Report cover image

Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Ob

Publisher Fatpos Global
Published Feb 01, 2025
Length 587 Pages
SKU # FAGL19863368

Description

Anti-inflammatory Drugs Market Size, Share, and Analysis, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Immune Selective Anti-inflammatory Derivatives, Anti-inflammatory Biologics, and Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease, Multiple Sclerosis, Inflammatory Bowel Disease (IBD), and Others), By Route of Administration (Oral, Topical, Injection, and Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Anti-inflammatory Drugs Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 111.4 billion and is projected to reach USD 264.3 billion by the completion of 2034.

Anti-inflammatory drugs reduce inflammation, which is the body's response to injury or infection. They stop the body from producing certain chemicals like prostaglandins which cause inflammation and pain. Anti-inflammatory drugs are often classified into different groups such as nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin, which block inflammation-related enzymes; and corticosteroids, which reduce inflammation by the suppression of the immune system. These medications are frequently used for the treatment of ailments such as arthritis, muscle discomfort, and various inflammatory diseases. Besides, while these drugs are effective, they can have adverse effects such as gastrointestinal difficulties and a high risk of cardiovascular disease if used for an extended period.

MARKET HIGHLIGHTS

Anti-inflammatory drugs market is projected to reach USD 264.3 billion over the forecast period, owing to a rise in chronic inflammatory conditions, like arthritis and autoimmune diseases. The market for anti-inflammatory drugs includes a variety of products, which range from prescription to over-the-counter medications. Innovation in drug formulations and targeted therapy is boosting the growth of the market by improving efficacy and lowering side effects. In addition, biologics and next-generation NSAIDs are becoming highly popular due to their effectiveness and safety characteristics. Moreover, pharmaceutical companies and new biotech firms are engaged in competitive dynamics as they continue to conduct research to find modern treatments. Besides, the industry is experiencing high activity in strategic partnerships and acquisitions, which are expanding the range of therapies.

Anti-inflammatory Drugs Market Segments:
  • By Drug Type
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Immune Selective Anti-inflammatory Derivatives
  • Anti-inflammatory Biologics
  • Corticosteroids
  • By Application
  • Arthritis
  • Chronic Obstructive Pulmonary Disease
  • Multiple Sclerosis
  • Inflammatory Bowel Disease (IBD)
  • Others
  • By Route of Administration
  • Oral
  • Topical
  • Injection
  • Inhalation
  • By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
MARKET DYNAMICS

Growth Drivers

Rising Prevalence of Chronic Inflammatory Diseases is Driving Growth in the Anti-inflammatory Drugs Market

Advancements in Drug Development Act as a Catalyst for Market Growth

Restraint

Side Effects and Safety Concerns in the Market Will Impact the Growth

Key Players
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis International AG
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Sanofi S.A.
  • Roche Holding AG
  • Eli Lilly and Company
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • Takeda Pharmaceutical Company Limited
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 2-3 business days upon order confirmation*

Table of Contents

587 Pages
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Anti-inflammatory Drugs Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Anti-inflammatory Drugs Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Anti-inflammatory Drugs Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Anti-inflammatory Drugs Market
10.1. Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Anti-inflammatory Drugs Market Size & Forecast 2024 A-2034 F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Drug Type
11.3.1.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
11.3.1.1.1. By Value (USD Million) 2024-2034 F
11.3.1.1.2. Market Share (%) 2024-2034 F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.1.2. Immune Selective Anti-Inflammatory Derivatives
11.3.1.2.1. By Value (USD Million) 2024-2034 F
11.3.1.2.2. Market Share (%) 2024-2034 F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.1.3. Anti-Inflammatory Biologics
11.3.1.3.1. By Value (USD Million) 2024-2034 F
11.3.1.3.2. Market Share (%) 2024-2034 F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.1.4. Corticosteroids
11.3.1.4.1. By Value (USD Million) 2024-2034 F
11.3.1.4.2. Market Share (%) 2024-2034 F
11.3.1.4.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2. By Application
11.3.2.1. Arthritis
11.3.2.1.1. By Value (USD Million) 2024-2034 F
11.3.2.1.2. Market Share (%) 2024-2034 F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.2. Chronic Obstructive Pulmonary Disease
11.3.2.2.1. By Value (USD Million) 2024-2034 F
11.3.2.2.2. Market Share (%) 2024-2034 F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.3. Multiple Sclerosis
11.3.2.3.1. By Value (USD Million) 2024-2034 F
11.3.2.3.2. Market Share (%) 2024-2034 F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.4. Inflammatory Bowel Disease (IBD)
11.3.2.4.1. By Value (USD Million) 2024-2034 F
11.3.2.4.2. Market Share (%) 2024-2034 F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034 F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2024-2034 F
11.3.2.5.2. Market Share (%) 2024-2034 F
11.3.2.5.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3. By Route of Administration
11.3.3.1. Oral
11.3.3.1.1. By Value (USD Million) 2024-2034 F
11.3.3.1.2. Market Share (%) 2024-2034 F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3.2. Topical
11.3.3.2.1. By Value (USD Million) 2024-2034 F
11.3.3.2.2. Market Share (%) 2024-2034 F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3.3. Injection
11.3.3.3.1. By Value (USD Million) 2024-2034 F
11.3.3.3.2. Market Share (%) 2024-2034 F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034 F
11.3.3.4. Inhalation
11.3.3.4.1. By Value (USD Million) 2024-2034 F
11.3.3.4.2. Market Share (%) 2024-2034 F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034 F
11.3.4. By Distribution Channel
11.3.4.1. Hospital Pharmacies
11.3.4.1.1. By Value (USD Million) 2024-2034 F
11.3.4.1.2. Market Share (%) 2024-2034 F
11.3.4.1.3. Y-o-Y Growth (%) 2024-2034 F
11.3.4.2. Retail Pharmacies
11.3.4.2.1. By Value (USD Million) 2024-2034 F
11.3.4.2.2. Market Share (%) 2024-2034 F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034 F
11.3.4.3. Online Pharmacies
11.3.4.3.1. By Value (USD Million) 2024-2034 F
11.3.4.3.2. Market Share (%) 2024-2034 F
11.3.4.3.3. Y-o-Y Growth (%) 2024-2034 F
12. North America Anti-inflammatory Drugs Market Size & Forecast 2024 A-2034 F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Drug Type
12.3.2. By Application
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Anti-inflammatory Drugs Market Size & Forecast 2024 A-2034 F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Drug Type
13.3.2. By Application
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Anti-inflammatory Drugs Market Size & Forecast 2024 A-2034 F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Drug Type
14.3.2. By Application
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Anti-inflammatory Drugs Market Size & Forecast 2024 A-2034 F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Drug Type
15.3.2. By Application
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Anti-inflammatory Drugs Market Size & Forecast 2024 A-2034 F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Drug Type
16.3.2. By Application
16.3.3. By Route of Administration
16.3.4. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Pfizer Inc.
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Johnson & Johnson
18.3. Novartis International AG
18.4. GlaxoSmithKline plc
18.5. Bristol-Myers Squibb Company
18.6. Merck & Co., Inc.
18.7. AbbVie Inc.
18.8. Amgen Inc.
18.9. Sanofi S.A.
18.10. Roche Holding AG
18.11. Eli Lilly and Company
18.12. AstraZeneca plc
18.13. Boehringer Ingelheim GmbH
18.14. Takeda Pharmaceutical Company Limited
18.15. Other Prominent Players
19. Appendix
20. Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us